SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating significant momentum as investors anticipate the upcoming oral presentation of pancreatic cancer data at Digestive Disease Week, which follows recent FDA and European trial expansion successes. The community is actively discussing a series of near-term clinical milestones and institutional accumulation, viewing the stock as a de-risked opportunity with strong upside potential.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors react to the long-awaited FDA clinical hold lift for its gene-editing program and highly positive long-term Phase 3 results, which have triggered intense community discussion around a potential short squeeze given the stock's elevated short interest. While the community is actively debating the significance of the recent shelf offering and its impact on dilution, bullish sentiment remains strong regarding the company's curative technology and upcoming clinical trial milestones.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is gaining traction as the market highlights its origins as the first cryptocurrency parody from 2011, with community members actively discussing its shift from a long-standing forum joke to an on-chain asset. Enthusiasts are focusing on its historical significance, the involvement of original creators, and substantial long-term token locks as proof of its resilience and potential to outperform current market trends.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Domino's Pizza is currently drawing significant attention from investors who are closely watching the stock for a potential rebound following a period of range-bound price action and recent earnings volatility. Community sentiment remains polarized, with many market participants viewing the company as a deep-value opportunity and a potential candidate for long-term accumulation, while others express caution regarding competitive pressures and broader consumer spending trends.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera Inc. is trending as investors aggressively speculate on a potential major commercial licensing deal following an expanded collaboration with Synopsys and ongoing work with key equipment partners in the semiconductor space. The community is sharply divided between retail bulls anticipating a breakout on high volume and skeptics who highlight the company's long history of pre-revenue status and capital-raising activities.

RE/MAX Holdings, Inc. engages in the provision of real estate franchise services through its subsidiaries. It operates through the following segments: Real Estate, Mortgage and Marketing Funds. The Real Estate segment consists of the company’s owned and independent global franchising operations under the RE/MAX brand name and technology and data subscription for Gadberry and the First app. The Mortgage segment consists of the firm's mortgage brokerage franchising operations under the Motto Mortgage brand name and mortgage loan processing services and licensed software under the wemlo brand. The Marketing Funds segment is involved in marketing campaigns designed to build and maintain brand awareness and the development and operation of agent marketing technology. The company was founded by David L. Liniger and Gail A. Liniger in 1973 and is headquartered in Denver, CO.

RE/MAX Holdings Inc - Ordinary Shares - Class A

RE/MAX is currently drawing investor attention as it faces ongoing volatility within the broader housing market, with the community actively debating the company's valuation amid cooling home sales data and shifting industry dynamics. While some market participants view the stock as undervalued and point to recent insider buying as a sign of confidence, others remain cautious about potential headwinds from high interest rates and broader economic uncertainty.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is facing downward pressure as investors weigh strong record-breaking earnings against softer-than-expected guidance driven by handset memory shortages and broader semiconductor supply chain constraints. Despite these headwinds, the community remains divided, with many long-term bulls highlighting the company's aggressive stock buyback programs, massive automotive backlogs, and strategic pivot toward edge AI and data center opportunities as potential catalysts for a recovery.

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Compass Therapeutics Inc

Compass Therapeutics is trending as investors monitor the upcoming release of Phase 2/3 clinical trial results for tovecimig in biliary tract cancer, with the community closely tracking the potential survival benefits versus historical standards. Traders are focused on the volatility surrounding this binary event, debating whether the recent price movement and pre-announcement indicate positive data or institutional positioning.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing heightened community discussion ahead of the anticipated Goliath mainnet launch. While some users are expressing skepticism and frustration over prolonged price consolidation and perceived manipulation, bulls are actively accumulating and highlighting the potential for institutional adoption.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as investors debate whether the stock represents a significant long-term growth opportunity tied to AI infrastructure or an overextended, overbought asset. The community is sharply divided between bulls citing massive revenue growth and demand for data center optics, and skeptics who are warning of a potential rug-pull due to high RSI levels and lack of historical profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's How Much $1000 Invested In Schwab U.S. Large-Cap Growth ETF 10 Years Ago Would Be Worth Today

Here's How Much You Would Have Made Owning Schwab U.S. Large-Cap Growth ETF Stock In The Last 10 Years

Should Schwab U.S. Large-Cap Growth ETF (SCHG) Be on Your Investing Radar?

<ul class="summary-bullets"><li>The DraftKings class action lawsuit was originally filed in April 2024.</li><li>DraftKings asked the court to rule in its favor by submitting graphic depictions of how it contended that it disclosed the terms and conditions of the promotion to the plaintiffs, according to the PHAI.&nbsp;</li><li>Ruling denying the bulk of DraftKings' motion for Summary Judgement marks the first false advertising lawsuit against DraftKings Sportsbook to survive this stage.</li></ul>The Public Health Advocacy Institute (PHAI) on Tuesday announced that its class action lawsuit against DraftKings will proceed toward class certification, class-wide discovery, and trial after a Massachusetts Superior Court judge rejected most of DraftKings' Motion for Summary Judgment.The class action challenges DraftKings' advertised "$1,000 Deposit Bonus" promotion for new sportsbook customers in Massachusetts.Ruling denying the bulk of DraftKings' motion for Summary Judgment marks the first false advertising lawsuit against DraftKings Sportsbook to survive this stage, clearing the way for class certification and trial, the institute said in its statement.&nbsp;<h2 class="st-heading-2">Details</h2>The DraftKings class action lawsuit was originally filed in April 2024 by Melissa Scanlon and Sean Harris who&nbsp;contended that DraftKings failed to adequately disclose terms and conditions to obtain the advertised bonus.DraftKings asked the court to rule in its favor by submitting graphic depictions of how it contended that it disclosed the terms and conditions of the promotion to the plaintiffs, according to the PHAI.&nbsp;<h2 class="st-heading-2">Sports Betting&nbsp;</h2>The lawsuit comes at a time when DraftKings has grown to be a major player&nbsp;among sports betting websites in the U.S. The firm is now expanding its reach to global markets.&nbsp;The company launched its online sportsbook in Puerto Rico, further expanding DraftKings reach to more users. “DraftKings’ online sportsbook will be available to Puerto Rico residents beginning February 23, 2026, following the recent opening of the DraftKings retail sportsbook at Foxwoods El San Juan Casino in November,” it said.&nbsp;Since 2013, the American Psychiatric Association has classified Gambling Disorder in the same diagnostic category as substance-related addictions, including cocaine, opioids, tobacco, alcohol, and heroin, reflecting the well-established public health risks associated with gambling-related harm.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around DKNG trended in ‘bearish’ territory amid ‘extremely low’ message volume.&nbsp;Shares in the company have fallen nearly 52% over the past year.&nbsp;

In this photo illustration, the logo of DraftKings Inc. is displayed on a smartphone screen. 

DraftKings’ Stock In Focus As PHAI’s Lawsuit Will Proceed To Trial

The class action challenges DraftKings' advertised "$1,000 Deposit Bonus" promotion for new sportsbook customers in Massachusetts.

Equity

The class action challenges DraftKings' advertised "$1,000 Deposit Bonus" promotion for new sportsbook customers in Massachusetts.


<ul class="summary-bullets"><li>Morgan Stanley’s price target represents a 27% upside to Thursday’s closing price of $334.74.</li><li>The firm sees further upward revisions to GE Aerospace’s earnings and free cash flow.</li><li>Morgan Stanley views the stock’s risk/reward profile as attractive, with a favorable skew of about 2.9 times at current levels.</li></ul>Shares of GE Aerospace jumped to a record high in pre-market trading on Friday after the company received a bullish nod from Morgan Stanley, calling it a ‘best-in-class’ aerospace and defense company.Morgan Stanley initiated coverage of the stock with an ‘Overweight’ rating and a price target of $425, according to The Fly. This represents a 27% upside to Thursday’s closing price of $334.74.<a href="https://stocktwits.com/symbol/GE">GE</a> climbed above 1% and was among the top trending tickers at the time of writing.<h2 class="st-heading-2">Morgan Stanley Sees GE Aerospace As A ‘Structural Winner’&nbsp;</h2>The firm highlighted GE Aerospace’s ‘deep competitive moat’ in an industry with high barriers to entry and long product cycles, noting that the company is well positioned as a structural winner, supported by steady demand for aircraft engines and services.Morgan Stanley expects further upward revisions to earnings and free cash flow, highlighting confidence in the company’s long-term growth prospects. At current prices, the firm views the stock’s risk/reward profile as attractive, with potential gains significantly outweighing losses. It estimates a favorable skew of about 2.9 times.According to TradingView data, GE Aerospace has a price-to-earnings (P/E) ratio of 40.5, compared to Lockheed Martin’s (LMT) P/E of 30.2.<h2 class="st-heading-2">American Airlines Chooses CFM Engines For Airbus A321neo Fleet Expansion</h2>On Thursday, American Airlines (AAL) said its upcoming Airbus A321neo deliveries will continue to be powered by CFM International’s LEAP-1A engines, with CFM also providing long-term maintenance support. CFM is a 50/50 joint venture between GE Aerospace and Safran Aircraft Engines.In addition to its CFM-powered fleet, the airline operates Boeing 777s with GE90 engines and Boeing 787 Dreamliners with GEnx engines, with more aircraft on order.Earlier this month, GE Aerospace also unveiled a $300 million multi-year investment plan to expand its engine component repair capacity in Singapore through 2029.<h2 class="st-heading-2">Strong Q4 Print To Drive Stock Price In 2026</h2>GE Aerospace <a href="https://stocktwits.com/news-articles/markets/equity/ge-aerospace-shares-tumble-despite-upbeat-earnings/cmUC9MGR4Xm">reported</a> strong fourth-quarter results last month, revenue growing 17.6% year-on-year to $12.72 billion, earnings rising by 32% to $8.05 per share, and operating profit margin soaring 21.4% to 70 bps. Its total orders jumped to $66.2 billion, up more than 32%The company also expects a low-double-digit revenue growth and adjusted EPS of $7.10 to $7.40 in 2026. The results led to a slew of bullish brokerage actions, with UBS stating that the higher numbers are expected to drive the stock in 2026.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>Despite the favorable recent developments, retail sentiment on Stocktwits has remained in the ‘bearish’ zone for over a month.<img src="https://news.stocktwits-cdn.com/GE_jpg_792adf6d1a.webp" alt="GE.jpg">One user called the stock “ridiculously expensive” and pegged its fair Value at $220.<stembedurl>https://stocktwits.com/Itsokman/message/645413721</stembedurl>Another user noted that the stock remains in a clear uptrend after breaking past a key resistance level.<stembedurl>https://stocktwits.com/GettnFibbywIT/message/645210742</stembedurl>Year-to-date, GE shares have gained nearly 10%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nasdaq-sp500-futures-higher-nvda-tsla-app-gral-ibrx-stocks-to-watch/cZRZz0BR4xP">Nasdaq, S&amp;P 500 Futures Rise Before PCE Report, Likely Tariff Ruling: Why NVDA, TSLA, GOOGL, IBRX, APP, GRAL Are On Traders' Radar Today</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the GE Aerospace logo is displayed on a smartphone screen. (Photo illustration by Cheng Xin/Getty Images)

GE Stock On Track To Hit All-Time High: Morgan Stanley Calls It A ‘Structural Winner’, Flags 27% Upside 

Morgan Stanley initiated coverage of the stock with an ‘Overweight’ rating and a price target of $425, according to The Fly.

This Aerospace Stock Got A Big Wall Street Nod – And It Is On Track To Hit All-Time High

Morgan Stanley initiated coverage of the stock with an ‘Overweight’ rating and a price target of $425, according to The Fly.


Schwab U.S. Large-Cap Growth (SCHG) Enters Oversold Territory

In trading on Tuesday, shares of the Schwab U.S. Large-Cap Growth ETF (Symbol: SCHG) entered into oversold territory, changing hands as low as $30.085 per share. We define oversold territory using...

<ul class="summary-bullets"><li>Wealth-management stocks slid on Tuesday after tech platform Altruist introduced an AI-powered tax planning tool.</li><li>Wurster said the selloff left him “disappointed and surprised” because he believes that AI would strengthen advisers’ capabilities.</li><li>Schwab is well-positioned to benefit from AI due to its scale and extensive data, Wurster added.</li></ul>Charles Schwab (SCHW) CEO Rick Wurster pushed back against growing concerns that artificial intelligence could disrupt the wealth management industry, arguing instead that the technology will enhance adviser productivity.Wurster emphasized that AI should be viewed as a supportive tool rather than a replacement for human expertise, according to a Bloomberg interview on Wednesday. “With the power of AI, not only are we reaching those clients we have a relationship with, we are able to help a whole new group of clients,” Wurst said.His comments came after a selloff that dragged down shares of several wealth-management firms following the launch of Altruist’s AI-powered tax planning tool on Tuesday.<a href="https://stocktwits.com/symbol/SCHW">SCHW stock</a> was down 3% in morning trade after closing over 7% lower in the previous session.<h2 class="st-heading-2">Altruist’s AI Tool Leads To Selloff</h2>Wealth-management stocks slid on Tuesday after tech platform Altruist introduced an AI-powered tax planning tool within its Hazel platform, raising concerns about pressure on traditional advisory services. Shares of Raymond James Financial fell over 8%, while Stifel Financial declined around 4% on Tuesday.The tool analyzes client financial data to create personalized tax strategies, aiming to improve outcomes and efficiency. Altruist added that strict zero data-retention agreements ensure customer information is not stored or used to train AI models.<h2 class="st-heading-2">Wurster Says He Is Disappointed And Surprised By Recent Selloff</h2>Wurster said the decline in the brokerage’s shares left him “disappointed and surprised” because he believes that artificial intelligence would strengthen advisers’ capabilities rather than replace them.“The market is missing that we are a natural winner in the AI space because of all of the advantages we have — because of our size, our scale, our data,” he said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment shifted to ‘bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/SCHW_jpg_af0628c78b.webp" alt="SCHW.jpg">However, some users expressed concerns about the company’s future amid the “AI onslaught”.<stembedurl>https://stocktwits.com/Free43ver/message/644650446</stembedurl><stembedurl>https://stocktwits.com/Mahaperrotta/message/644618898</stembedurl>SCHW stock has shed over 3% so far in 2026.was up 1.6% in pre-market trading after closing over 7% lower in the previous session.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/khc-stock-slumps-weak-q4-results-pauses-separation/cZb6X4CR4qY">Kraft Heinz Pauses Separation Plan Amid Weak Q4 Print – KHC Stock Slumps 7% Pre-Market</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Charles Schwab company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Charles Schwab CEO Reportedly Explains Why AI Won’t Disrupt Wealth Management Industry: ‘We Are Able To Help A Whole New Group Of Clients’

CEO Rick Wurster said that AI should be viewed as a supportive tool rather than a replacement for human expertise, according to an interview with Bloomberg on Wednesday.

SCHG
Schwab Strategic Trust - Schwab U.S. Large-Cap Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest SCHG News

SCHGSchwab Strategic Trust - Schwab U.S. Large-Cap Growth ETF